Verge Genomics, a clinical-stage, tech-enabled biotechnology company using artificial intelligence (AI) and human data to transform drug discovery, has announced today that the first subject has been dosed in a…
…including the ongoing collaboration with WHO’s Hub for Pandemic and Epidemic Intelligence, to allow for faster data-driven decision-making at the earliest signs of an outbreak – when it matters most.”…
A new system utilising artificial intelligence (AI), ‘building-block’ chemistry and a molecule-making machine could speed up innovation and drug discovery, as well as make complex chemistry automated and accessible. Researchers…
…to a CRO that specialises in artificial intelligence (AI) and machine learning software to predict compounds that bind to a target. Company Z would generate candidates in weeks rather than…
…latest technology; trends and analysis; and articles and intelligence from the DDW quarterly publication including archived issues. To download the DDW app for Apple devices click here. To download the…
…the future will include decentralised elements and be more reliant on technologies like artificial intelligence, but also increasingly patient-centric. As a result of the pandemic companies and sites conducting clinical…
…Brainomix will leverage its e-ILD technology (automated artificial intelligence software) which has been trained to process high resolution chest CT (HRCT) data in patients with interstitial lung diseases. The data…
Biopharmaceutical company Sosei Group received both Licensing Deal of the Year and Executive of the Year at the first Informa Pharma Intelligence Awards Japan. The Informa Pharma Intelligence Awards Japan…
…healthcare sector and is the author of over 30 peer-reviewed scientific articles. Dr Anvar holds a PhD in Medicine from Leiden University, and an MSc in Bioinformatics and Artificial Intelligence…
Technology company PeakData has raised €12.1 million in Series A funding to support its artificial intelligence (AI) platform. Launched in 2018, PeakData enables pharmaceutical companies to uncover the whole therapeutic…
…signs $20m research agreement with Atomwise Artificial intelligence (AI) company Atomwise has signed an exclusive research collaboration with Sanofi to use its AtomNet platform for computational discovery and research of…
…transformative therapeutics and diagnostics in chronic multi-factorial diseases,” said Angeli Möller, PhD, Vice-Chairperson and co-founder of the Alliance for Artificial Intelligence in Healthcare, the global advocacy organization for applying AI…
…big data and artificial intelligence (AI). Access the summer issue on the app The DDW App can be downloaded for free for Apple and Android devices to access content online…
…digital twin to assist CAR-T development Artificial intelligence (AI) solutions provider Phesi has developed a digital twin for Cytokine Release Syndrome (CRS) patients following CAR-T therapy. SMC opens new pharma…
…opportunity to accelerate our growth plans. We look forward to welcoming new, highly talented software specialists and scientists dedicated to delivering our best-in-class in silico technologies and Artificial Intelligence platforms.”…
Artificial intelligence (AI) solutions provider Phesi has developed a digital twin for Cytokine Release Syndrome (CRS) patients following CAR-T therapy. Phesi has developed the digital twin for CRS in order…
